Adaptimmune Therapeutics PLC reports

Company location: Abingdon, Oxfordshire
Fiscal year end: 31 December

Adaptimmune Therapeutics PLC has filed 808 SEC EDGAR filings since 02 Oct 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
20-F
6-K

SEC filing history

Showing 401-425 of 808 matching filings.

Per page

25

Current page

17

4

FORM 4 SUBMISSION

Filing date: 28 Jan 2020
Reporting date: 24 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-233557

424B5

Filing date: 22 Jan 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37368

FORM 8-K

Filing date: 22 Jan 2020
Reporting date: 21 Jan 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B5 File 333-233557

424B5

Filing date: 21 Jan 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 17 Jan 2020
Reporting date: 16 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 17 Jan 2020
Reporting date: 16 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 17 Jan 2020
Reporting date: 16 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 17 Jan 2020
Reporting date: 16 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 17 Jan 2020
Reporting date: 16 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 15 Jan 2020
Reporting date: 14 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 15 Jan 2020
Reporting date: 14 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 15 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 15 Jan 2020
Reporting date: 14 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 15 Jan 2020
Reporting date: 14 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 15 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37368

FORM 8-K

Filing date: 14 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

3

3

Filing date: 13 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37368

FORM 8-K

Filing date: 13 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37368

FORM 8-K

Filing date: 13 Jan 2020
Reporting date: 13 Jan 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 07 Jan 2020
Reporting date: 06 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 07 Jan 2020
Reporting date: 06 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 07 Jan 2020
Reporting date: 06 Jan 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37368

FORM 8-K

Filing date: 26 Nov 2019
Reporting date: 23 Nov 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-37368

10-Q

Filing date: 06 Nov 2019
Reporting date: 30 Sep 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37368

FORM 8-K

Filing date: 06 Nov 2019
Reporting date: 06 Nov 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .